Krishna Institute of Medical Sciences Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 4 Aug 2026

Company page: Krishna Institute of Medical Sciences share price, financials & guidance record

KIMS Hospitals reported strong top-line and EBITDA growth in Q1 FY27, driven by robust patient volumes and the ramp-up of new units. Significant debt reduction was achieved through a QIP, improving the balance sheet. While new units like Mahadevapura are performing well, PAT saw a decline, and some units are still in the ramp-up phase, with an old facility continuing to incur costs.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 29.8%, net profit up 11.9% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	363	348	346	373	430 +18%	442 +27%	456 +32%	484 +30%
Expenses	252	245	237	276	318	314	326	365
EBITDA	111	103	109	98	112 +1%	128 +24%	130 +19%	118 +20%
Margin	31%	30%	31%	26%	26%	29%	29%	24%
Other income	7	21	35	12	12	14	11	31
Interest	5	7	8	12	18	22	27	33
Depreciation	14	15	15	18	20	23	26	27
Profit before tax	99	102	120	80	86 −13%	98 −4%	89 −26%	89 +11%
Tax rate	27%	25%	22%	26%	26%	26%	26%	25%
Net profit	72	76	94	59	64 −11%	72 −5%	66 −30%	66 +12%
EPS	1.80	1.91	2.34	1.47	1.59	1.81	1.65	1.58

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls